Business Description
Nexentis Technologies Inc
NAICS : 325314
SIC : 2875
ISIN : US80512Q5018
Total Employee Number:
5Compare
Compare
Traded in other countries / regions
NXTS.USA80W0.Germany IPO Date
2009-12-15Description
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.11 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -4.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 81.4 | |||||
3-Year EPS without NRI Growth Rate | 71 | |||||
3-Year FCF Growth Rate | 79.9 | |||||
3-Year Book Growth Rate | -72.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.6 | |||||
9-Day RSI | 43.63 | |||||
14-Day RSI | 45.75 | |||||
3-1 Month Momentum % | 21.98 | |||||
6-1 Month Momentum % | -50.13 | |||||
12-1 Month Momentum % | -91.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.73 | |||||
Quick Ratio | 4.73 | |||||
Cash Ratio | 3.56 | |||||
Days Inventory | 1429.58 | |||||
Days Payable | 2263 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -409.2 | |||||
Shareholder Yield % | -5.45 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 106.06 | |||||
Operating Margin % | 10639.39 | |||||
Net Margin % | 14228.79 | |||||
EBITDA Margin % | 16016.67 | |||||
FCF Margin % | 6977.27 | |||||
OCF Margin % | 6693.94 | |||||
ROE % | -98.61 | |||||
ROA % | -74.59 | |||||
ROIC % | -88.5 | |||||
3-Year ROIIC % | 3.08 | |||||
ROC (Joel Greenblatt) % | -3719.53 | |||||
ROCE % | -96.46 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.23 | |||||
Price-to-Tangible-Book | 0.39 | |||||
EV-to-EBIT | -0.02 | |||||
EV-to-EBITDA | -0.02 | |||||
EV-to-Revenue | -3.35 | |||||
EV-to-FCF | -0.05 | |||||
Price-to-GF-Value | 1.23 | |||||
| Price-to-Net-Current-Asset-Value | 0.63 | |||||
| Price-to-Net-Cash | 1.1 | |||||
Earnings Yield (Greenblatt) % | -5000 | |||||
FCF Yield % | -75.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NXTS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nexentis Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.066 | ||
| EPS (TTM) ($) | -48.489 | ||
| Beta | 1.9055 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.55 | ||
| Volatility % | 70.01 | ||
| 14-Day RSI | 45.75 | ||
| 14-Day ATR ($) | 1.735018 | ||
| 20-Day SMA ($) | 5.51 | ||
| 12-1 Month Momentum % | -91.08 | ||
| 52-Week Range ($) | 3.38 - 89.792498 | ||
| Shares Outstanding (Mil) | 1.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nexentis Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nexentis Technologies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-16 09:30 | In 166 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 132 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 41 days | ||
| First quarter earnings results for 2026 | 2026-05-14 | 4.71 (+1.95%) | ||
| 0.142857:1 Stock Split | 2026-04-08 | 4.19 (-2.85%) | ||
| Annual report for 2025 | 2026-03-31 | 4.37 (-1.95%) | ||
| General meeting for 2025 | 2025-12-16 09:30 | 19.60 (-6.67%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 22.40 (-2.44%) | ||
| 0.0285714:1 Stock Split | 2025-09-22 | 36.31 (-8.18%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 58.09 (-1.21%) |
Show
Entries
Nexentis Technologies Inc Frequently Asked Questions
What is Nexentis Technologies Inc(NXTS)'s stock price today?
The current price of NXTS is $4.17. The 52 week high of NXTS is $89.79 and 52 week low is $3.38.
When is next earnings date of Nexentis Technologies Inc(NXTS)?
The next earnings date of Nexentis Technologies Inc(NXTS) is 2026-08-14 Est..
Does Nexentis Technologies Inc(NXTS) pay dividends? If so, how much?
Nexentis Technologies Inc(NXTS) does not pay dividend.
Guru Commentaries on NAS:NXTS
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Save Foods, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) | 2022-11-11 |
Articles on Nexentis Technologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers